Some Phase II trials are randomized, meaning patients are randomly assigned to either the treatment group or a control group. This design helps in minimizing bias and provides more robust data on the treatment’s efficacy compared to the control. Randomized trials are especially useful in comparing the new treatment to the current standard of care.
